title: [Damage to peripheral nerves induced by Campylobacter jejuni exotoxin].
abstract: OBJECTIVE
  To explore the pathogenesis of the damage to peripheral nerves induced by Campylobacter jejuni exotoxin (CJT).
  
  
  METHODS
  (1) Animal models: (1) The CJT was extracted from PEN 19-CJ and injected perineurally and intravenously to Wistar rats. (2) The sera and the supernatants of peripheral blood mononuclear cells (PBMCs), taken from the rats immunized with the CJT, were injected perineurally at sciatic nerves of experimental rats and intravenously, respectively. (2) Histopathologic study of sciatic nerves: the animals were sacrificed and their sciatic nerves were examined for tease fibers, transverse section with toluidine blues staining and electron microscopy. (3) Immunohistochemistry: sections of sciatic nerves of either normal rats or human which were incubated with CJT and the sciatic nerves with pathological changes induced by CJT were obtained for observation of the binding capability of CJT with peripheral nerves by SABC and FITC-immunofluorescence methods, and nucleic acid hybridization techniques for detection of TNF-alpha mRNA expression in pathological sciatic nerves samples.
  
  
  RESULTS
  (1) Remarkable peripheral neuropathies with axon degeneration and/or demyelination were found in the nerves induced by both CJT injection perineurally and intravenously. The axon degeneration was more obvious. Pathological changes were identified in 76.8% (2,763/3,600) of teasing fibers after perineural injection, but only 9.6% (230/2,400) of fibers were damaged in control group (P < 0.01). The peak severity of fiber damage was found on the 3rd day after CJT intravenous injection with the incidence of abnormal fibers was 19.5% (390/2,000), and abnormalities of 15.5% (310/2000) on the 14th day. However, no abnormal changes were demonstrated in control group (P < 0.01). So was in the groups injected with anti-CJT sera and the supernatants of PBMCs compared with control (P > 0.05). (2) Binding of CJT to the nerve was found dominant in the sciatic nerves taken from normal rats or human either incubated with CJT or in the pathological sciatic nerves induced by CJT to various degrees. The binding of CJT to all these nerves was determined. (3) After intravenous injection with CJT, no histopathologic change could be found in the other viscera of the rats, with the exception of remarkable pathological change in peripheral nerves.
  
  
  CONCLUSIONS
  (1) CJT could remarkably damage the peripheral nerves in rats. Specific pathogenicity of CJT to peripheral nerves was well shown, because no histopathologic abnormalities could be found in the other viscera, such as brain, liver and kidney etc. although there was remarkable pathological change along the peripheral nerve in the animals. (2) No immunological pathogenicity of CJT could be demonstrated in the nerves of rats after immunization with CJT.
authors.affiliation: Department of Neurology, Children's Hospital, Chongqing University of Medical Sciences, Chongqing 400014, China.
authors.forename: Long-shan
authors.initials: LS
authors.lastname: Xie
authors.forename: Fang-cheng
authors.initials: FC
authors.lastname: Cai
authors.forename: Yu-xing
authors.initials: YX
authors.lastname: Gao
authors.forename: Xiao-ping
authors.initials: XP
authors.lastname: Zhang
mesh_terms: D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000097:blood; D001427:Bacterial Toxins / Q000276:immunology / Q000633:toxicity*; D016123:Campylobacter jejuni / Q000276:immunology; D005098:Exotoxins / Q000276:immunology / Q000633:toxicity*; D015870:Gene Expression / Q000187:drug effects; D010525:Peripheral Nerves / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D012584:Sciatic Nerve / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics
chemical_list: D000888:Antibodies, Anti-Idiotypic; D001427:Bacterial Toxins; D005098:Exotoxins; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; C048844:anti-IgG